Results 111 to 120 of about 1,940,581 (174)

Hepatorenal and Full Blood Count Profiles of Stroke Survivors Compared With Controls: A Case–Control Study

open access: yesFASEB BioAdvances, Volume 8, Issue 10, October 2026.
In a case–control study of 69 participants (20 stroke survivors, 49 controls; aged 31–78 years) at Tamale Teaching Hospital, Ghana (March–September 2025), venous blood was analyzed for full blood count, liver and renal function. After adjusting for BMI and occupation, stroke survivors showed higher indirect bilirubin (0.143 mmol/L) and MCHC (0.398 g/dL)
Moses Banyeh   +18 more
wiley   +1 more source

Asthma, tuberculosis or eosinophilic pneumonia?

open access: yesLung India, 2007
A 45 year-old male presented with cough and expectoration for 8 months, short-ness of breath and wheeze for 3 months, and fever for 1 month. He remained symptomatic despite repeated courses of antibiotics with partial relief on oral and inhaled ...
Mitra Subhra, Kundu Somenath
doaj  

Chronic Eosinophilic Pneumonia as the Initial Manifestation of Rheumatoid Arthritis: A Case Report

open access: yesAnnals of Internal Medicine: Clinical Cases
Chronic eosinophilic pneumonia (CEP) is a rare disorder characterized by peripheral blood eosinophilia, increased eosinophils in bronchoalveolar lavage fluid, and eosinophilic infiltration of lung alveoli and interstitia. While only a handful of cases of
Nuzhat Batool   +4 more
doaj   +1 more source

The lung is more than an organ of gas exchange: immunocompetency, platelets and implications for drug discovery

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 20, Page 5999-6006, October 2026.
Abstract The lungs have for a long time been recognised as having pharmacological significance as a specific organ to modulate the pharmacokinetics of endogenous substances needed to maintain homeostasis. The lungs are therefore the site of action of certain drugs that act on these homeostatic processes, resulting in systemic effects on the ...
Simon C. Pitchford
wiley   +1 more source

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, Volume 56, Issue 10, Page 1162-1176, October 2026.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 10, October 2026.
COPD is a heterogeneous disease driven by overlapping neutrophilic and eosinophilic inflammatory pathways. This review highlights the shift from symptom‐based treatment toward phenotype‐ and biomarker‐directed care. Blood eosinophils, FeNO, and IgE predict corticosteroid responsiveness and identify candidates for biologic therapy.
Sasha Raman   +3 more
wiley   +1 more source

Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle‐Invasive Urothelial Carcinoma

open access: yesInternational Journal of Urology, Volume 33, Issue 10, October 2026.
ABSTRACT Objectives Perioperative immunotherapy has become the standard of care in patients with high‐risk muscle‐invasive urothelial carcinoma (MIUC). This study aimed to clarify oncological outcomes and safety profiles of adjuvant nivolumab therapy in MIUC, focusing on upper tract urothelial carcinoma (UTUC).
Satoshi Katayama   +19 more
wiley   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1648-1661, October 2026.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta   +5 more
wiley   +1 more source

Acute eosinophilic pneumonia accompanied by mediastinal lymphadenopathy and thrombocytopenia [PDF]

open access: yes, 2006
Acute eosinophilic pneumonia, which was described in 1989, is thought to represent a hypersensitivity reaction to unidentified inhaled antigens.
Unlu, Mehmet   +4 more
core  

Home - About - Disclaimer - Privacy